You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國信證券:首次覆蓋給予環球醫療(2666.HK)買入評級,合理股價7.89~9.81港幣
格隆匯 09-26 14:52
格隆匯9月26日丨國信證券9月24日發研報稱,環球醫療(2666.HK)是醫療融資租賃起家、緊抓政策機遇順利轉型醫療服務的央企。金融業務增長穩健的同時,醫療服務業務成長快速,且已成為拉動業績成長的主要因素。 國信證券預計環球醫療2021-23年歸母淨利潤為20/23/28億人民幣,增速24%/17%/16%,當前股價對應PE 5/4/3X。綜合絕對估值和相對估值,公司合理股價在7.89~9.81港幣, 相較當前股價5.88港幣(9月23日收盤價)有34%~67%溢價空間,首次覆蓋,給予“買入”評級。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account